Form: S-8

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

April 14, 2014

 

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We have issued our report dated March 19, 2014, with respect to the consolidated financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2013 of Cellectar Biosciences, Inc. and subsidiary, which are incorporated by reference in this Registration Statement. We consent to the incorporation by reference in the Registration Statement of the aforementioned report.

 

/s/ Grant Thornton LLP  
   
Chicago, Illinois  
April 14, 2014